Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
Pharmacological inhibition of the MEK5/ERK5 and PI3K/Akt signaling pathways synergistically reduces viability in triple-negative breast cancer. [electronic resource] by
- Wright, Thomas D
- Raybuck, Christopher
- Bhatt, Akshita
- Monlish, Darlene
- Chakrabarty, Suravi
- Wendekier, Katy
- Gartland, Nathan
- Gupta, Mohit
- Burow, Matthew E
- Flaherty, Patrick T
- Cavanaugh, Jane E
Producer: 20210129
In:
Journal of cellular biochemistry vol. 121
Availability: No items available.
|
|
5.
|
Structure activity relationships of anthranilic acid-based compounds on cellular and in vivo mitogen activated protein kinase-5 signaling pathways. [electronic resource] by
- Chakrabarty, Suravi
- Monlish, Darlene A
- Gupta, Mohit
- Wright, Thomas D
- Hoang, Van T
- Fedak, Mitchel
- Chopra, Ishveen
- Flaherty, Patrick T
- Madura, Jeffry
- Mannepelli, Shankar
- Burow, Matthew E
- Cavanaugh, Jane E
Producer: 20190109
In:
Bioorganic & medicinal chemistry letters vol. 28
Availability: No items available.
|
|
6.
|
Novel Diphenylamine Analogs Induce Mesenchymal to Epithelial Transition in Triple Negative Breast Cancer. [electronic resource] by
- Bhatt, Akshita B
- Gupta, Mohit
- Hoang, Van T
- Chakrabarty, Suravi
- Wright, Thomas D
- Elliot, Steven
- Chopra, Ishveen K
- Monlish, Darlene
- Anna, Katie
- Burow, Matthew E
- Cavanaugh, Jane E
- Flaherty, Patrick T
Publication details: Frontiers in oncology 2019
In:
Frontiers in oncology vol. 9
Availability: No items available.
|